DENVER, Nov. 19, 2010 (GLOBE NEWSWIRE) — MusclePharm(R) Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States, today announced former UFC light heavyweight champion, Lyoto Machida, will be wearing MusclePharm apparel at the main fight which takes place on Saturday, November 20, 2010 in Auburn Hills, Michigan. UFC newcomer Maiquel Jose Falcao Goncalves will also sport MusclePharm’s apparel on the UFC 123 Fight Card that includes his fight shorts, t-shirt, hat, and a banner with the MSLP Ticker Symbol. UFC 123 Event will draw an estimated 850,000 pay per view buys and is watched by an estimated 10 million viewers. “We are very excited to have one of our UFC athletes compete in the main event fight. UFC continues to be a tremendous partner for MusclePharm as we increase our consumer demographic exposure during Saturday night’s fight,” commented Cory Gregory, MusclePharm’s President. “We will continue to focus on opportunities with UFC to further increase MusclePharm’s brand awareness and expand MusclePharm’s supplement and apparel market penetration.” Lyoto “The Dragon” Machida (fighting out of Belem, Brazil / 16-1) is a black belt in Brazilian jiu-jitsu and Machida Karate. The former UFC light heavyweight champion won his first 16 professional fights. Winning five of his first six fights in the UFC, the 32-year-old has finished three bouts, including a submission win over Rameau Sokoudjou and knock out victories against Thiago Silva and Rashad Evans. Maiquel Jose Falcao Goncalves is a Brazilian mixed martial artist. He was signed to make a debut at UFC 123 against Gerald Harris. Prior to his UFC appearance, Maiquel collected a 25-3 record with only one win coming by way of decision and 23 of the wins coming by knockout or TKO. About MusclePharmHeadquartered in Denver, Colorado, MusclePharm is a rapidly expanding healthy life-style company that develops and manufacturers a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. The Company’s propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 US retail outlets that include GNC, and Vitamin Shoppe, as well as over 100 online stores, including bodybuilding.com, Amazon and Vitacost.com. For more information, please visit www.musclepharm.com. Forward-looking StatementsMusclePharm Corporation believes the information set forth in this Press Release may include “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. Certain factors that could cause results to differ materially from those projected in the forward-looking statements are set forth in “Risk Factors” in Item 2.02 of the Company’s Form 8-K dated February 18, 2010, which has been filed with the Securities and Exchange Commission. Contact:ICR
Investor Contact:
John Mills, Senior Managing Director
310.954.1105
CRWEnewswire is not liable for the contents of this news, as well as not being liable for any errors or delays in the content, or for any actions taken in reliance thereon.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
No comments:
Post a Comment